Vitamin D and Stroke

Vitamin D and Stroke: A Comparative Study to Risk Factors and Stroke Type

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02916030

Enrollment

Registered

2016-09-27

Start date

2016-09-01

Completion date

2017-01-03

Last updated

2018-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Vitamin D, Stroke, Parathormone

Brief summary

Stroke remains one of the most devastating neurological diseases, often causing death, or gross physical impairment. It is the second most common cause of death worldwide and a major cause of acquired disability in adults.Vitamin D deficiency has been reported to contribute to the risk of cardiovascular disease especially stroke.

Detailed description

This case -control observational prospective study will conducted on fifty patients with first -ever acute onset stroke within seven days (25 patients with hemorrhagic stroke and 25 patients with ischemic stroke )

Interventions

DIETARY_SUPPLEMENTVit D

It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Onset is within one week * Confirmed stroke by brain CAT and / or MRI scan either haemorrhage or infarction

Exclusion criteria

* Cognitive and mental changes * Recurrent stroke * Hepatic and renal impairment * Endocrinal diseases * Steroid therapy * Vitamin D or Ca supplementation * Previous fractures * Bone diseases * brain neoplasm, * Autoimmune diseases * History of acute and chronic inflammatory diseases * Malignancy, * Trauma * Surgery * Acute vascular diseases that occurred within four weeks prior the onset of stroke * History myocardial infarction ˂3 months.

Design outcomes

Primary

Measure	Time frame	Description
serum 25 (OH) D levels	Within the first 24 hours	serum 25 (OH) D levels

Secondary

Measure	Time frame	Description
Stroke severity	Within the first 24 hours	Stroke severity will be assessed by Scandinavian Stroke scale Stroke (SSS)
Stroke etiology	Within the first 24 hours	—
Stroke risk factors	Within the first 24 hours	—
Stroke subtypes	Within the first 24 hours	—

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026